Saswata Roy

Saswata Roy has over 20 years of experience in the pharmaceutical and biotechnology sectors, currently serving as Associate Director of QA Validation at Ultragenyx Pharmaceutical Inc. since January 2022, where responsibilities include managing quality personnel and leading the validation strategy for a new gene therapy facility. Previously, Saswata held roles at AbbVie, ascending from Senior Engineer to Principal Engineer, where oversight of a $10 million capital validation group and involvement in various project initiatives were key functions. Earlier experience includes significant contributions at Abbott Laboratories and G & W Laboratories, focusing on validation protocols, investigation documentation, and regulatory compliance. Educational qualifications include an MS in Biotechnology Engineering from Tufts University, a MEng in Chemical Engineering from Stevens Institute of Technology, and a BE in Chemical Engineering from the University of Mumbai. Acclaimed for outstanding performance across multiple roles, Saswata has received numerous awards for contributions to quality assurance and validation efforts.